AI Science Tracker
EN

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response.

Department of Neurosurgery · 26 Aug 2022 · biology

Discovery

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature; the source analyzes TCGA LGG (475), then CGGA cohorts (170 and 420) for prognostic and clinicomolecular replication. Drug/immune response findings are computational response estimates, not demonstrated treatment benefit.

Technology: Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature.
Limitation / still unknown
Drug/immune response findings are computational response estimates, not demonstrated treatment benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.942966/full · https://pubmed.ncbi.nlm.nih.gov/36090045/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.